Our Experience with Hyaluronic Acid-Carboxymethylcellulose Membrane in Cesarean Sections
10.2185/jjrm.64.125
- VernacularTitle:帝王切開術でのヒアルロン酸ナトリウム／カルボキシメチルセルロース癒着防止吸収性バリアの使用経験
- Author:
Koji SHIMABUKURO
;
Seiichi ENDO
;
Yasuko NISHIDA
;
Yoshihide SAGAWA
;
Kaori TAKAGI
;
Mayumi KOBAYASHI
;
Reiko NAKAMURA
;
Tamami ODAI
;
Kotoi TSURANE
;
Fumi KURITA
;
Yoko FUJIOKA
;
Maiko ICHIKAWA
;
Naoyuki MIYASAKA
;
Masae SAKAMOTO
- Publication Type:Journal Article
- From:Journal of the Japanese Association of Rural Medicine
2015;64(2):125-130
- CountryJapan
- Language:Japanese
-
Abstract:
Adhesion formation after abdominal surgery is a commonly recognized entity. Many studies have shown that women giving birth by cesarean section are at the risk of developing complications related to the postoperative formation of adhesions including ileus, bowel obstructions, impaired fertility, and chronic abdominal pain. Among several adhesion barriers, one that has been tested in randomized, controlled trials is the hyaluronic cid-carboxymethylcellulose (HA/CMC) membrane (Seprafilm®: Genzyme, Cambridge, MA, USA). This bioresorbable membrane serves as a mechanical barrier between surgically damaged tissues and resorbs afterwards. At our institution, we have used HA/CMC in cesarean sections. We report our experience with this patient population using placement of HA/CMC. This study enrolled 45 women who had undergone cesarean sections twice or more who had received HA/CMC during the previous cesarean section between January 2013 and November 2014. The incidence of adhesions to the area of abdominal wall incisions and uterine surface, intestinal obstructive symptoms, and adverse events were studied. The incidence of adhesions to midline incisions was 4.4% (n＝2). The filmy adhesion by major omentum was detected in these two cases. The incidence of adhesions to uterine surface was 2.2% (n＝1). The moderate thickness adhesion was detected at the left side of the vesico-uterine peritoneal incision by pelvic peritoneum which did not affect the operative procedure. No symptoms related to intestinal obstructions such as abdominal pains, nausea and vomiting were observed. No adverse events were observed. These three cases had fever which had nothing to do with HA/CMC applications but was attributable respectively to influenza infection, mastitis, phlebitis associated with a needle procedure. HA/CMC was considered a useful adhesion barrier membrane for use in cesarean sections as an adjunct intended to reduce the incidence of postoperative adhesions between the abdominal wall and the underlying viscera such as omentum, small bowel, and between the uterus and surrounding structures.
